Dutch biotech startup CryoCloud secures €500K funding: Know more
Summary
Robert Englmeier, CEO of CryoCloud, states, “The landscape and throughput of cryo-EM has evolved significantly in the last six years, yet the way data is analysed remained the same – leading to bottlenecks and creating entrance barriers. Our mission is to make cryo-EM more accessible and to streamline the research process, which is now possible with our platform.” Founded by Robert Englmeier, Ilja Gubins, and Boy Persoon in 2021, CryoCloud has developed a proprietary data analysis platform — cryoEM. Consequently, it addresses the critical challenges faced by the scientific community, including the high costs, complexity, and inefficiencies associated with traditional cryo-EM compute infrastructure. By offering scalable cloud storage and data analysis workflows through a user-friendly web app, the Dutch company is making advanced research tools more accessible to scientists worldwide. Marta-Gaia Zanchi, Founder & Managing Partner at Nina Capital says, “CryoCloud’s innovative approach to leveraging cloud technology in cryo-EM is not just a major step for structural biology, but a testament to the transformative power of digital solutions in the life sciences sector.” Utrecht Health Seed Fund (UHSF) is an early-stage life sciences & health investment fund based out of Utrecht, The Netherlands.
Funding
Review available funding amount, funding date, investors, and linked company information related to Dutch biotech startup CryoCloud secures €500K funding: Know more in the interactive ISVWorld profile.